Skip to main content
Muller & Phipps (India) Ltd. logo

Muller & Phipps (India) Ltd. — Investor Relations & Filings

Ticker · 501477 ISIN · INE003F01015 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 248 across all filing types
Latest filing 2024-11-13 Regulatory Filings
Country IN India
Listing BSE.NS 501477

About Muller & Phipps (India) Ltd.

https://mulphico.swayantra.com/

Muller & Phipps (India) Ltd. focuses on the marketing and distribution of consumer healthcare, personal care, and home care products. The company manages a portfolio of established brands, including Sloan's Liniment and Nixoderm, specializing in over-the-counter pharmaceuticals and medicated skin care solutions. Its core operations involve managing complex supply chains and logistics networks to facilitate product placement across retail and pharmaceutical channels. The organization provides integrated brand management services, including sales strategy and distribution logistics, to ensure consistent market availability. By utilizing an extensive infrastructure and historical expertise in brand representation, the company serves as a key intermediary between manufacturing entities and the end-consumer market, maintaining a focus on quality and accessibility in its product range.

Recent filings

Filing Released Lang Actions
Financial Results for the quarter and half year ended 30-09-2024
Regulatory Filings
2024-11-13 English
Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 we would like to inform you that the Board of Directors ....
Regulatory Filings
2024-11-13 English
MULLER & PHIPPS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve Pursuant to Regulation ....
Regulatory Filings
2024-11-05 English
Compliance under Reg 74(5) for the quarter ended 30-09-2024
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended 30th September 2024. It is a compliance certificate issued by the Registrar and Share Transfer Agent to the company and stock exchange. The document is short (2770 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is not an announcement of a report but a certificate itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2024-10-18 English
Clarification on Price Movement as per email dated 08-10-2024
Regulatory Filings
2024-10-09 English
Intimation for closure of trading
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about the commencement of a trading restriction period related to the upcoming declaration of unaudited financial results for the quarter and half year ended September 30, 2024. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The document does not contain any financial data, detailed report, or results itself, but is an announcement related to trading restrictions ahead of financial results publication. The length is only 1058 characters, indicating it is a brief regulatory announcement rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-30 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.